4/2
Bioengineering
On a different wavelength, Nader Engheta leads a community in light
2023 Franklin Medal winner Engheta is one of the world’s biggest names in wave physics. The Penn Engineering professor is renowned for his unique approach to science, combining technical brilliance, creativity, and care.
Why is machine learning trending in medical research but not in our doctor’s offices?
Penn Integrates Knowledge Professor Konrad Kording will lead Penn’s NIH-funded cohort for making advancements in the field of machine learning in biomedical research by creating the Community for Rigor, which will provide open-access resources on conducting sound science.
Nanorobotic system presents new options for targeting fungal infections
Researchers from Penn Dental and Penn Engineering have developed a nanorobot system that precisely and rapidly targets fungal infections in the mouth.
Four Penn students are 2023 Goldwater Scholars
Goldwater Scholarships are awarded to students planning research careers in mathematics, the natural sciences, or engineering.
Novel tools for the treatment and diagnosis of epilepsy
Penn neurologist Brian Litt’s work on implantable devices for recording and altering brain activity has led to new ways to treat and diagnose epilepsy.
Gregory Bowman appointed Penn Integrates Knowledge University Professor
The pioneer of biophysics and data science has joint appointments in the Department of Biochemistry and Biophysics in the Perelman School of Medicine and the Department of Bioengineering in the School of Engineering and Applied Science.
More cancers may be treated with drugs than previously believed
Using a Penn-designed neural network called PocketMiner, a Penn Medicine research team has identified hidden protein pockets that can provide new opportunities for cancer drugs to bind to.
A potential strategy to improve T cell therapy in solid tumors
A new Penn Medicine preclinical study finds that a new simultaneous “knockout” of two inflammatory regulators boosted T cell expansion to attach solid tumors.
Targeted prenatal therapy addresses long-standing gap in health equity
Penn engineers have developed a successful delivery system of mRNA to placental cells to treat preeclampsia at its root.
New insights into the mechanisms of tumor growth
A team of researchers led by the School of Arts & Science’s Wei Guo characterize the molecular pathways that play a major role in tumorigenesis, findings that could lead to better diagnostic tools for cancer and new targeted therapies.
In the News
Can your personal medical devices be recycled?
A lab at the School of Engineering and Applied Science led the development of a COVID test made from bacterial cellulose, an organic compound.
FULL STORY →
Scientists think they’re on the verge of breaching the blood-brain barrier
Michael Mitchell of the School of Engineering and Applied Science and colleagues have constructed a model that could potentially allow drug transporters to bypass the blood-brain barrier.
FULL STORY →
How severed cockroach legs could help us ‘fully rebuild’ human bodies
David Meaney of the School of Engineering and Applied Science oversees an undergraduate bioengineering lab that uses cockroach legs to teach students to work with human prostheses.
FULL STORY →
Herniated discs could be repaired with biologic patch one day, researchers say
Preclinical research by Robert Mauck of the Perelman School of Medicine, Thomas Schaer of the School of Veterinary Medicine, and Ana Peredo, a Ph.D. graduate of the School of Engineering and Applied Science, reveals how a biologic patch activated by natural motion could become a key tool for repairing herniated discs in the back and relieving pain.
FULL STORY →
Thanks, Neanderthals: How our ancient relatives could help find new antibiotics
A study by César de la Fuente of the Perelman School of Medicine and colleagues used AI to recreate molecules from ancient humans that could be potential candidates for antimicrobial treatments.
FULL STORY →
Why CAR T cell therapy is the cancer killer the world needs now
Research from Michael Mitchell of the School of Engineering and Applied Science has developed a new method to stop cytokine release during CAR T cell therapy, preventing some of its more dangerous side effects.
FULL STORY →